Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference


BOULDER, Colo., May 30, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2018 Global Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Jefferies 2018 Global Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Wednesday, June 6, 2018

Time:

2 p.m. Eastern Time

Webcast:

http://wsw.com/webcast/jeff113/arry/

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other conditions. Ten registration studies are currently advancing related to eight Array-owned or partnered drugs: encorafenib (LGX818), binimetinib (MEK162), ARRY-797, selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Seattle Genetics). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:       
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
[email protected]

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

 

SOURCE Array BioPharma


These press releases may also interest you

at 16:15
Universal Logistics Holdings, Inc. Named a 2023 Supplier of the Year by General Motors
Universal Logistics Holdings, Inc. was named a 2023 Supplier of the Year by General Motors ("GM"). GM celebrated honorees at its 32nd annual Supplier of the Year event in Miami, Florida last week....

at 16:10
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

at 16:10
Smartsheet Announces $150 Million Share Repurchase Program
Smartsheet , the enterprise work management platform, today announced that its Board of Directors has authorized the repurchase of up to $150 million of the company's outstanding Class A common stock through open market purchase, block trades, and/or...

at 15:57
Slovenia Signs Artemis Accords, Joins Pursuit of Safer Space
NASA and Slovenia affirmed their cooperation in future space endeavors on Friday as Slovenia became the 39th country to sign the Artemis Accords. The signing certified Slovenia's commitment to pursue safe and sustainable exploration of space for the...

at 15:55
Valley Mountain Regional Center Provides Notice Following Data Security Incident
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...

More news about Science and technology...


News published on and distributed by: